Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy
Status:
Completed
Trial end date:
2000-09-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine whether albuterol increases strength in patients with
facioscapulohumeral dystrophy as measured by quantitative voluntary isometric contraction
testing.
II. Determine whether albuterol increases muscle mass in this patient population as
determined by 24 hour urinary creatinine excretion and dual energy x-ray absorptiometry
(DEXA).
III. Examine the long term safety of albuterol in this patient population.